Consilium Strategic Communications was formed in 2013 following a management buyout by Mary-Jane Elliott. Mary-Jane has more than 20 years of healthcare experience from leading communications agencies and the pharmaceutical industry and is an expert in financial, corporate, investor and scientific communications.
Prior to founding Consilium, Mary-Jane set up and ran the international healthcare practice at M:Communications where she advised a range of public and private companies internationally across all sub-sectors of healthcare. She has extensive experience having led the advisory work on a wide range of high profile IPOs, secondary fundraisings, private equity placements, friendly and hostile M&A transactions, crisis communications, clinical data and product launches.
Mary-Jane previously spent six years at WPP’s Financial PR firm, Buchanan Communications, as a Partner, where she advised a range of companies across the healthcare and other sectors.
Prior to moving to the City, Mary-Jane worked for six years at PowderJect Pharmaceuticals plc in Oxford, UK as a scientist before joining the corporate communications team and until the takeover by Chiron Corporation in 2003. She was previously a scientist at Bell Laboratories Inc., in Madison, Wisconsin, US. Mary-Jane has a BSc (Hons) in BioMedical Sciences.